Solstice Raises Series A to Radically Accelerate Pharma Commercialization

Transformation Capital leads $21M investment in Solstice, enabling pharma brands to slash medical, legal, and regulatory marketing review cycles from weeks to less than 48 hours NEW YORK, May 28, 2026 /PRNewswire/ -- Solstice, the AI-native marketing agency accelerating pharma...